Exploring the therapeutic potential of phytochemicals in Alzheimer's disease: Focus on polyphenols and monoterpenes

I Piccialli, V Tedeschi, L Caputo, S D'Errico… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a chronic, complex neurodegenerative disorder mainly
characterized by the irreversible loss of memory and cognitive functions. Different …

The blood–brain barrier and its intercellular junctions in age-related brain disorders

L Costea, Á Mészáros, H Bauer, HC Bauer… - International journal of …, 2019 - mdpi.com
With age, our cognitive skills and abilities decline. Maybe starting as an annoyance, this
decline can become a major impediment to normal daily life. Recent research shows that the …

Cerebrovascular pathology during the progression of experimental Alzheimer's disease

P Giannoni, M Arango-Lievano, ID Neves… - Neurobiology of …, 2016 - Elsevier
Clinical and experimental evidence point to a possible role of cerebrovascular dysfunction in
Alzheimer's disease (AD). The 5xFAD mouse model of AD expresses human amyloid …

Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity

DM Lyall, SR Cox, LM Lyall, C Celis-Morales… - Brain imaging and …, 2020 - Springer
Apolipoprotein (APOE) e4 genotype is an accepted risk factor for accelerated cognitive
aging and dementia, though its neurostructural substrates are unclear. The deleterious …

Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease

H Chen, H Wan, M Zhang, G Liu, X Wang… - Parkinsonism & Related …, 2021 - Elsevier
Introduction Emerging evidence has suggested that cerebral small vessel disease (CSVD)
may worsen motor function and cognition in Parkinson's disease (PD). However, the effect of …

Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice

C Hong, Z Wang, S Zheng, W Hu, S Wang… - Acta Pharmacologica …, 2023 - nature.com
Aging is one of the main risk factors for cognitive dysfunction. During aging process, the
decrease of brain-derived neurotrophic factor (BDNF) and the impairment of astrocyte …

A white matter connection of schizophrenia and Alzheimer's disease

P Kochunov, A Zavaliangos-Petropulu… - Schizophrenia …, 2021 - academic.oup.com
Schizophrenia (SZ) is a severe psychiatric illness associated with an elevated risk for
developing Alzheimer's disease (AD). Both SZ and AD have white matter abnormalities and …

Hypertension and age-related cognitive impairment: common risk factors and a role for precision aging

M Hay, C Barnes, M Huentelman, R Brinton… - Current Hypertension …, 2020 - Springer
Abstract Purpose of Review Precision Aging® is a novel concept that we have recently
employed to describe how the model of precision medicine can be used to understand and …

Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology

M Ries, H Watts, BC Mota, MY Lopez, CK Donat… - Brain, 2021 - academic.oup.com
Alzheimer's disease, characterized by brain deposits of amyloid-β plaques and
neurofibrillary tangles, is also linked to neurovascular dysfunction and blood–brain barrier …

Cerebrovascular phenotypes in mouse models of Alzheimer's disease

JI Szu, A Obenaus - Journal of Cerebral Blood Flow & …, 2021 - journals.sagepub.com
Alzheimer's disease (AD) is a devastating neurological degenerative disorder and is the
most common cause of dementia in the elderly. Clinically, AD manifests with memory and …